Clinical Trial

The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The objectives/purpose of this study are to comprehensively investigate the effects of non-prescription CBD on driving performance, drowsiness, sedation, and cognitive function in a large sample of healthy adults aged 18-30 years, with additional characterization of effects by dose and by sex, using a rigorous RCT design which will naturally mitigate confounding factors.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-11-11; most recent amendment 2025-10-29.
Status change: Not Yet Recruiting → Recruiting 2025-04-14
Trial Details
NCT Number NCT06686914
Lead Sponsor West Virginia University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Cannabidiol Effects, Driving Performance
Enrollment 300 participants
Start Date 2025-06-30
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-31